Leap Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Leap Therapeutics is a clinical-stage biotechnology company focused on developing targeted and immuno-oncology therapeutics for cancer. Headquartered in Cambridge, Massachusetts, it operates from 47 Thorndike Street, Suite B1-1, and employs 11-50 people. The company trades on NASDAQ under the ticker LPTX and maintains a website at leaptx.com. Its pipeline includes sirexatamab and FL-501, reflecting its focus on advancing cancer therapeutics through preclinical and clinical development. In 2025, Leap Therapeutics pursued private financing and reported participation in major conferences to share data from its programs, including presentations at AACR and ESMO.